TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 82 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,912,186 | -40.8% | 103,744 | 0.0% | 0.50% | -40.2% |
| Q2 2023 | $6,613,100 | +156.7% | 103,744 | -2.0% | 0.84% | +128.9% |
| Q1 2023 | $2,575,828 | -16.3% | 105,914 | 0.0% | 0.37% | -9.6% |
| Q4 2022 | $3,075,743 | -41.5% | 105,914 | -39.7% | 0.41% | -73.4% |
| Q3 2022 | $5,262,000 | -16.1% | 175,520 | +1.2% | 1.52% | +27.0% |
| Q2 2022 | $6,274,000 | -10.9% | 173,520 | +6.6% | 1.20% | -10.6% |
| Q1 2022 | $7,039,000 | -11.8% | 162,703 | +2.2% | 1.34% | +77.5% |
| Q4 2021 | $7,978,000 | +25.4% | 159,203 | +59.2% | 0.76% | -76.1% |
| Q3 2021 | $6,363,000 | -11.6% | 100,000 | 0.0% | 3.16% | +22.3% |
| Q2 2021 | $7,196,000 | – | 100,000 | – | 2.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 565,951 | $24,483,000 | 8.44% |
| Murchinson Ltd. | 162,703 | $7,039,000 | 1.34% |
| Eversept Partners, LP | 220,286 | $9,529,572 | 0.73% |
| BRANDES INVESTMENT PARTNERS, LP | 379,322 | $16,410,000 | 0.35% |
| Analyst IMS Investment Management Services Ltd. | 17,657 | $764,000 | 0.07% |
| Claret Asset Management Corp | 7,279 | $315,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 326,427 | $14,086,000 | 0.06% |
| Renaissance Technologies | 678,300 | $29,343,000 | 0.03% |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 191,820 | $8,298,000 | 0.03% |
| ARK Investment Management | 55,566 | $2,404,000 | 0.01% |